US Bancorp’s Palvella Therapeutics, Inc. Common Stock PVLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-138
| Closed | -$1.66K | – | 4372 |
|
|
2024
Q4 | $1.66K | Hold |
138
| – | – | ﹤0.01% | 3883 |
|
|
2024
Q3 | $2.29K | Sell |
138
-20
| -13% | -$332 | ﹤0.01% | 3740 |
|
|
2024
Q2 | $1.55K | Buy |
158
+29
| +22% | +$285 | ﹤0.01% | 3734 |
|
|
2024
Q1 | $1.88K | Hold |
129
| – | – | ﹤0.01% | 3723 |
|
|
2023
Q4 | $1.87K | Hold |
129
| – | – | ﹤0.01% | 3704 |
|
|
2023
Q3 | $3.06K | Hold |
129
| – | – | ﹤0.01% | 3553 |
|
|
2023
Q2 | $1.7K | Hold |
129
| – | – | ﹤0.01% | 3688 |
|
|
2023
Q1 | $10K | Hold |
129
| – | – | ﹤0.01% | 3269 |
|
|
2022
Q4 | $10.7K | Hold |
129
| – | – | ﹤0.01% | 3265 |
|
|
2022
Q3 | $12K | Hold |
129
| – | – | ﹤0.01% | 3304 |
|
|
2022
Q2 | $19K | Hold |
129
| – | – | ﹤0.01% | 3083 |
|
|
2022
Q1 | $31K | Hold |
129
| – | – | ﹤0.01% | 2836 |
|
|
2021
Q4 | $39K | Hold |
129
| – | – | ﹤0.01% | 2767 |
|
|
2021
Q3 | $53K | Hold |
129
| – | – | ﹤0.01% | 2617 |
|
|
2021
Q2 | $39K | Hold |
129
| – | – | ﹤0.01% | 2781 |
|
|
2021
Q1 | $26K | Hold |
129
| – | – | ﹤0.01% | 2898 |
|
|
2020
Q4 | $26K | Hold |
129
| – | – | ﹤0.01% | 2784 |
|
|
2020
Q3 | $21K | Hold |
129
| – | – | ﹤0.01% | 2766 |
|
|
2020
Q2 | $32K | Hold |
129
| – | – | ﹤0.01% | 2562 |
|
|
2020
Q1 | $23K | Hold |
129
| – | – | ﹤0.01% | 2634 |
|
|
2019
Q4 | $37K | Hold |
129
| – | – | ﹤0.01% | 2598 |
|
|
2019
Q3 | $35K | Hold |
129
| – | – | ﹤0.01% | 2625 |
|
|
2019
Q2 | $48K | Hold |
129
| – | – | ﹤0.01% | 2546 |
|
|
2019
Q1 | $34K | Hold |
129
| – | – | ﹤0.01% | 2661 |
|
|
2018
Q4 | $27K | Hold |
129
| – | – | ﹤0.01% | 2705 |
|
|
2018
Q3 | $58K | Hold |
129
| – | – | ﹤0.01% | 2488 |
|
|
2018
Q2 | $52K | Hold |
129
| – | – | ﹤0.01% | 2568 |
|
|
2018
Q1 | $70K | Hold |
129
| – | – | ﹤0.01% | 2420 |
|
|
2017
Q4 | $78K | Hold |
129
| – | – | ﹤0.01% | 2379 |
|
|
2017
Q3 | $59K | Buy |
+129
| New | +$59K | ﹤0.01% | 2492 |
|